July 2012 Volume 8, Issue 7
Volume 8, Issue 7 | July 2012
July 2012
In this Issue
Omics & Systems Biology
From pilot to partners
Novartis, Foundation Medicine build on oncology genome analysis collaborationNew on the singles scene
Broad Institute and Fluidigm launch new research center to focus on mammalian single-cell genomicsReal-time liquid biopsy
Fluxion Biosciences and Rubicon Genomics to collaborate on tracking down circulating tumor cellsAn A+ partnership on hemophilia B
Baxter, Chatham partner on Factor IX gene therapyBGI, Asian Cancer Research Group publish genome-wide study of hep B virus
Study focused on hepatitis B virus integration in hepatocellular carcinomaDoes persistence pay off?
GSK extends offer to acquire Human Genome Sciences, details remain the sameGovernment Watch
Taking the fifth
PDUFA legislation is reauthorized by House and Senate for fifth time since 1992I spy with my little eye …
FDA’s I-Spy 2 trial aims to make cancer drug approvals faster, more efficientCalifornia bill seeks restrictions on genetic data
Some researchers concerned that broad provisions will impede genetic researchSupreme Court decision delivers clarity to generic drugmakers
Caraco v. Novo Nordisk clarifies Congress’ intention in Hatch-Waxman ActSpecial Reports
Epigenetics: Half of the picture (PART 1)
Science plugs stem cells into epigenetic opportunities that control various disease statesEpigenetics: Half of the picture (PART 2)
Science plugs stem cells into epigenetic opportunities that control various disease statesDiagnostics
Casting a clinical eye
Agilent to acquire Dako for $2.2 billion as it looks to growth in clinical diagnostics marketLast man standing
LabCorp acquires MEDTOX Scientific, one of two remaining major independent clinical labsSpanning the melanoma continuum
HTG Molecular Diagnostics, John Wayne Cancer Institute partner to commercialize melanoma signaturesIn their blood
Biocartis, Philips and Wellcome Trust to develop automated blood-based assay system for monitoring tumor loadExosome chooses Life
Exosome Diagnostics will use Life Technologies’ real-time PCR platform for exosome biofluid oncology diagnosticsResearch & Development
International team tackles cancer
BMS launches global academic collaboration to focus on immuno-oncologyA pair of Northern lights
Canada’s Actium Research, McMaster University announce partnershipRacking the brain
Researchers at MD Anderson Cancer Center, two California biotechs lead effort to create new treatments for glioblastoma multiformeTaking a long, hard look at HER
GE Healthcare and Affibody team up on HER2-specific PET imaging agent for breast and gastric cancerOn the hunt for Huntington’s disease therapy
Lundbeck, CHDI to conduct preclinical studies on a Lundbeck investigative compoundTau Therapeutics and NCI launch Phase Ib trial in brain cancer
Tau Therapeutics LLC, a pharmaceutical company developing T-type calcium channel inhibitors for the treatment of solid tumors, announced today that it has opened enrollment for a Phase Ib clinical trialCommentary
Meeting the need for large-scale production of stem cells
As demand for stem cells for both drug discovery and clinical applications grows, effectively translating the promise of stem cells into therapeutic reality will require large-scale “industrialized” production under tightly controlled conditions.Out of Order: Good news and good luck
Bad news isn’t inherently bad just because it’s not what we expected or wanted, and it should be allowed to inform our subsequent decisions just as much as the good news. We’re just going to have to learn to discuss it like adults.Editor's Focus
Crohn’s a very personal disease
My sister Nina has Crohn’s disease, and a severe form of it at that. She never complained much -- she even had a sense of humor about a disease that some people consider unfit for polite conversation.Global News
Art of the deals
Takeda announces plans to acquire Brazil’s Multilab just before closing deal on U.S.-based URL PharmaBrazil beckons to Belgium
Belgium-based UCB partners with emerging market Brazil-based Meizler to create Meizler UCB BiopharmaJust what the doctor ordered
Dr. Reddy’s, Merck to collaborate on biosimilarsProbing the bowels of disease
Crohn’s and Colitis Foundation of Canada, Vertex Pharmaceuticals lead industry-academic quest to uncover biology of IBDTools & Technology
No more ‘garbage in, garbage out’
Seeking better data analysis in histology, Flagship Biosciences acquires IHCtechPop-up informatics
Robust SaaS workspace accelerates and streamlines collaborative drug discovery for virtual teamsA*STAR for Hitachi
Hitachi and Singapore’s A*STAR design novel method to reduce genome data storageHarnessing ISH and IHC
Affymetrix and Leica collaborate on RNA in-situ hybridization tissue assay for research useCorning announces cell-culture automation collaboration with TAP Biosystems
Corning Life Sciences announced last month that it has entered into a collaboration with TAP Biosystems to provide a manufacturing automation solution for large-scale, attachment-dependent cell culture
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Technology Guide: Spatial biology techniques
Discover essential strategies and expert insights to navigate the expanding world of spatial biology.
Decoding the tumor microenvironment with immune profiling
Integrating multiplexed immunohistochemistry with spatial analysis offers a practical way to uncover tumor-immune dynamics.
